BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

134 related articles for article (PubMed ID: 9349233)

  • 1. bcl-2 and p53 protein expression in follicular lymphoma.
    Cooper K; Haffajee Z
    J Pathol; 1997 Jul; 182(3):307-10. PubMed ID: 9349233
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Presence of bcl-2 and p53 proteins in patients with non-Hodgkin's lymphoma at Zadar General Hospital].
    Skunca Z; Gverić-Krecak V; Dominis M; Planinc-Peraica A; Jaksić B
    Acta Med Croatica; 2004; 58(3):183-6. PubMed ID: 15503680
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Transformation of follicular lymphoma. Expression of p53 and bcl-2 oncoprotein, apoptosis and cell proliferation.
    Symmans WF; Katz RL; Ordoñez NG; Dalton H; Romaguera JE; Cabanillas F
    Acta Cytol; 1995; 39(4):673-82. PubMed ID: 7631541
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Complex diagnosis of follicular lymphomas].
    Tóth E; Schneider T; Melegh Z; Csernák E; Udvarhelyi N; Rosta A; Szentirmay Z
    Magy Onkol; 2005; 49(2):135-40. PubMed ID: 16249809
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Prognostic significance of p53 and matrix metalloproteinase-9 expression in follicular lymphoma.
    Pennanen H; Kuittinen O; Soini Y; Turpeenniemi-Hujanen T
    Eur J Haematol; 2008 Oct; 81(4):289-97. PubMed ID: 18616513
    [TBL] [Abstract][Full Text] [Related]  

  • 6. bcl-2 protein is strongly expressed in post-transplant lymphoproliferative disorders.
    Chetty R; Biddolph S; Kaklamanis L; Cary N; Stewart S; Giatromanolaki A; Gatter K
    J Pathol; 1996 Nov; 180(3):254-8. PubMed ID: 8958801
    [TBL] [Abstract][Full Text] [Related]  

  • 7. BNIP3 expression in follicular lymphoma.
    Sington J; Giatromanolaki A; Campo L; Turley H; Pezzella F; Gatter KC
    Histopathology; 2007 Apr; 50(5):555-60. PubMed ID: 17394490
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Expression of Bcl-2 in lung neuroendocrine tumours: comparison with p53.
    Wang DG; Johnston CF; Sloan JM; Buchanan KD
    J Pathol; 1998 Mar; 184(3):247-51. PubMed ID: 9614375
    [TBL] [Abstract][Full Text] [Related]  

  • 9. bcl-6 protein is identified in high-grade but not low-grade mucosa-associated lymphoid tissue lymphomas of the stomach.
    Omonishi K; Yoshino T; Sakuma I; Kobayashi K; Moriyama M; Akagi T
    Mod Pathol; 1998 Feb; 11(2):181-5. PubMed ID: 9504689
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Significantly different bcl-2 expression profiles in gastric and non-gastric primary extranodal high-grade B-cell lymphomas.
    Cogliatti SB; Griesser H; Peng H; Du MQ; Isaacson PG; Zimmermann DR; Maibach RC; Schmid U
    J Pathol; 2000 Dec; 192(4):470-8. PubMed ID: 11113864
    [TBL] [Abstract][Full Text] [Related]  

  • 11. An immunophenotypic and molecular study of primary large B-cell lymphoma of bone.
    Huebner-Chan D; Fernandes B; Yang G; Lim MS
    Mod Pathol; 2001 Oct; 14(10):1000-7. PubMed ID: 11598170
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Detection of p53 and bcl-2 protein in carcinoma of the renal pelvis and ureter including dysplasia.
    Furihata M; Sonobe H; Ohtsuki Y; Yamashita M; Morioka M; Yamamoto A; Terao N; Kuwahara M; Fujisaki N
    J Pathol; 1996 Feb; 178(2):133-9. PubMed ID: 8683378
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Bcl-6 p53 mutations in lymphomas carrying the bcl-2/Jh rearrangement.
    Bellido M; Capello D; Altés A; Estivill C; Gaidano G; Pujol R; Bordes R; Baiget M; Saglio G; Sierra J; Nomdedéu JF
    Haematologica; 2002 Sep; 87(9):908-17. PubMed ID: 12217802
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Changes in Bcl-2 and p53 expression in recurrent B-cell lymphomas.
    Ilyas M; Kendall M; Jalal H; Linton C; Rooney N
    J Pathol; 1996 Nov; 180(3):249-53. PubMed ID: 8958800
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Expression of p53 and retinoblastoma gene in high-grade nodal peripheral T-cell lymphomas: immunohistochemical and molecular findings suggesting different pathogenetic pathways and possible clinical implications.
    Pescarmona E; Pignoloni P; Santangelo C; Naso G; Realacci M; Cela O; Lavinia AM; Martelli M; Russo MA; Baroni CD
    J Pathol; 1999 Aug; 188(4):400-6. PubMed ID: 10440751
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Molecular and immunohistochemical characterization of B-cell lymphoma-2-negative follicular lymphomas.
    Hoeller S; Bihl MP; Zihler D; Cogliatti S; Ponzoni M; Zettl A; Went P; Foerster A; Hirschmann P; Tzankov A; Dirnhofer S
    Hum Pathol; 2012 Mar; 43(3):405-12. PubMed ID: 21855110
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Molecular, cytogenetic, and immunophenotypic characterization of follicular lymphoma grade 3B; a separate entity or part of the spectrum of diffuse large B-cell lymphoma or follicular lymphoma?
    Bosga-Bouwer AG; van den Berg A; Haralambieva E; de Jong D; Boonstra R; Kluin P; van den Berg E; Poppema S
    Hum Pathol; 2006 May; 37(5):528-33. PubMed ID: 16647949
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Frequency of bcl-2 expression in non-Hodgkin's lymphoma: a study of 778 cases with comparison of marginal zone lymphoma and monocytoid B-cell hyperplasia.
    Lai R; Arber DA; Chang KL; Wilson CS; Weiss LM
    Mod Pathol; 1998 Sep; 11(9):864-9. PubMed ID: 9758366
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The pattern and frequency of t(14;18) translocation and immunophenotype in Asian follicular lymphoma.
    Peh SC; Shaminie J; Tai YC; Tan J; Gan SS
    Histopathology; 2004 Nov; 45(5):501-10. PubMed ID: 15500654
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Prognostic significance of bcl-2, bax, and p53 expression in diffuse large B-cell lymphoma.
    Sohn SK; Jung JT; Kim DH; Kim JG; Kwak EK; Park Ti; Shin DG; Sohn KR; Lee KB
    Am J Hematol; 2003 Jun; 73(2):101-7. PubMed ID: 12749011
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.